Swiss National Bank’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.18M | Buy |
|
|||||
|
2025
Q2 | $4.85M | Buy |
|
|||||
|
2025
Q1 | $5.43M | Buy |
|
|||||
|
2024
Q4 | $8.15M | Buy |
|
|||||
|
2024
Q3 | $6.69M | Buy |
|
|||||
|
2024
Q2 | $5.84M | Buy |
|
|||||
|
2024
Q1 | $5.92M | Buy |
|
|||||
|
2023
Q4 | $3.71M | Sell |
|
|||||
|
2023
Q3 | $3.46M | Buy |
|
|||||
|
2023
Q2 | $1.48M | Buy |
|
|||||
|
2023
Q1 | $1.31M | Sell |
|
|||||
|
2022
Q4 | $1.66M | Buy |
|
|||||
|
2022
Q3 | $1.73M | Hold |
|
|||||
|
2022
Q2 | $1.64M | Buy |
|
|||||
|
2022
Q1 | $1.73M | Buy |
|
|||||
|
2021
Q4 | $2.02M | Buy |
|
|||||
|
2021
Q3 | $1.04M | Hold |
|
|||||
|
2021
Q2 | $935K | Buy |
|
|||||
|
2021
Q1 | $575K | Buy |
|
|||||
|
2020
Q4 | $511K | Hold |
|
|||||
|
2020
Q3 | $567K | Hold |
|
|||||
|
2020
Q2 | $634K | Buy |
|
|||||
|
2020
Q1 | $276K | Buy |
|
|||||
|
2019
Q4 | $449K | Hold |
|
|||||
|
2019
Q3 | $269K | Hold |
|
|||||
|
2019
Q2 | $448K | Buy |
|